Regulatory actions for April 14, 2025 April 14, 2025 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Argenx, Verve.Read More
Other news to note for April 14, 2025 April 14, 2025 Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Opthea, Oncozenge.Read More
Financings for April 14, 2025 April 14, 2025 Biopharmas raising money in public or private financings, including: Imbria, Oncolytics.Read More
Appointments and advancements for April 14, 2025 April 14, 2025 New hires and promotions in the biopharma industry, including: Arcutis, Corvus, Evecxia, Harvard, Imbria.Read More
Biggest gainers and losers for April 7-11, 2025 April 14, 2025 The top 10 biopharma stock gainers and losers for the week.Read More
Biopharma money raised: Jan. 1-April 10, 2025 April 11, 2025 Year-to-date money raised in public, private and other financings of biopharma companies.Read More
Money raised by biopharma April 11, 2025 Total raised in public, private and other financings of biopharma companies, comparing 2019-2024.Read More
Appointments and advancements for April 11, 2025 April 11, 2025 New hires and promotions in the med-tech industry, including: Intrinsic.Read More
Financings for April 11, 2025 April 11, 2025 Med-tech firms raising money in public or private financings, including: Okeiro, Venus Concept.Read More
In the clinic for April 11, 2025 April 11, 2025 Clinical updates, including trial initiations, enrollment status and data readouts and publications: RSP Systems.Read More